Related references
Note: Only part of the references are listed.Epidermal growth factor-like domain multiple 6 (EGFL6) promotes the migration and invasion of gastric cancer cells by inducing epithelial-mesenchymal transition
Fu-Chun Huo et al.
INVESTIGATIONAL NEW DRUGS (2021)
Progress toward improved understanding of antibody maturation
Sandor Vajda et al.
CURRENT OPINION IN STRUCTURAL BIOLOGY (2021)
EGFL6 promotes colorectal cancer cell growth and mobility and the anti-cancer property of anti-EGFL6 antibody
Ting-Yi Sung et al.
CELL AND BIOSCIENCE (2021)
EGFL6 expression in hair follicle central isthmus is dependent on the presence of terminal Schwann cells
Jiang-Ping Wei et al.
EXPERIMENTAL DERMATOLOGY (2020)
miR-6086 inhibits ovarian cancer angiogenesis by downregulating the OC2/VEGFA/EGFL6 axis
Binhua Wu et al.
CELL DEATH & DISEASE (2020)
Knockout of EGFL6 by CRISPR/Cas9 Mediated Inhibition of Tumor Angiogenesis in Ovarian Cancer
Wenhui Zhu et al.
FRONTIERS IN ONCOLOGY (2020)
Epigenomic Reprogramming toward Mesenchymal-Epithelial Transition in Ovarian-Cancer-Associated Mesenchymal Stem Cells Drives Metastasis
Huihui Fan et al.
CELL REPORTS (2020)
Development of therapeutic antibodies for the treatment of diseases
Ruei-Min Lu et al.
JOURNAL OF BIOMEDICAL SCIENCE (2020)
EGFL6 promotes cell proliferation in colorectal cancer via regulation of the WNT/-catenin pathway
Qing-Wei Zhang et al.
MOLECULAR CARCINOGENESIS (2019)
Trends in therapeutic antibody affinity maturation: From in-vitro towards next-generation sequencing approaches
Maryam Tabasinezhad et al.
IMMUNOLOGY LETTERS (2019)
Identification of genes with universally upregulated or downregulated expressions in colorectal cancer
Kai Song et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2019)
EGFL6 promotes breast cancer by simultaneously enhancing cancer cell metastasis and stimulating tumor angiogenesis
Jingnan An et al.
ONCOGENE (2019)
Validation of EGFL6 expression as a prognostic marker in patients with lung adenocarcinoma in Taiwan: a retrospective study
Chun-Chi Chang et al.
BMJ OPEN (2018)
Elevated EGFL6 modulates cell metastasis and growth via AKT pathway in nasopharyngeal carcinoma
Ziyu Zhu et al.
CANCER MEDICINE (2018)
Monoclonal antibodies: technologies for early discovery and engineering
Patrick J. Kennedy et al.
CRITICAL REVIEWS IN BIOTECHNOLOGY (2018)
Differential Effects of EGFL6 on Tumor versus Wound Angiogenesis
Kyunghee Noh et al.
CELL REPORTS (2017)
EGFL6 Regulates the Asymmetric Division, Maintenance, and Metastasis of ALDH+ Ovarian Cancer Cells
Shoumei Bai et al.
CANCER RESEARCH (2016)
Human carcinoma-associated mesenchymal stem cells promote ovarian cancer chemotherapy resistance via a BMP4/HH signaling loop
Lan G. Coffman et al.
ONCOTARGET (2016)
Antibody humanization by redesign of complementarity-determining region residues proximate to the acceptor framework
Karl J. M. Hanf et al.
METHODS (2014)
Application of human FcRn transgenic mice as a pharmacokinetic screening tool of monoclonal antibody
Kenta Haraya et al.
XENOBIOTICA (2014)
Aldehyde Dehydrogenase in Combination with CD133 Defines Angiogenic Ovarian Cancer Stem Cells That Portend Poor Patient Survival
Ines A. Silva et al.
CANCER RESEARCH (2011)
EGFL6 Promotes Endothelial Cell Migration and Angiogenesis through the Activation of Extracellular Signal-regulated Kinase
Shek Man Chim et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Human ovarian carcinoma-associated mesenchymal stem cells regulate cancer stem cells and tumorigenesis via altered BMP production
Karen McLean et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Therapeutic antibodies: successes, limitations and hopes for the future
Patrick Chames et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Tumor vascular proteins as biomarkers in ovarian cancer
Ronald J. Buckanovich et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Gene alterations identified by expression profiling in tumor-associated endothelial cells from invasive ovarian carcinoma
Chunhula Lu et al.
CANCER RESEARCH (2007)
A general method for greatly improving the affinity of antibodies by using combinatorial libraries
A Rajpal et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Development of humanized antibodies as cancer therapeutics
ZX Qu et al.
METHODS (2005)
Minimizing the immunogenicity of antibodies for clinical application
NR Gonzales et al.
TUMOR BIOLOGY (2005)
Monoclonal antibodies as therapeutic agents for cancer
M Harris
LANCET ONCOLOGY (2004)
Expression and localization of the inwardly rectifying potassium channel Kir7.1 in native bovine retinal pigment epithelium
DL Yang et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2003)
Share Paper
